Literature DB >> 9565194

Dysmorphic concern: prevalence and associations with clinical variables.

P Oosthuizen1, T Lambert, D J Castle.   

Abstract

OBJECTIVE: The aim of this paper is to describe the development of a questionnaire, the Dysmorphic Concern Questionnaire (DCQ), for the assessment of dysmorphic concern, and to establish correlations with clinical variables.
METHOD: Consecutive admissions to a psychiatric hospital were surveyed.
RESULTS: The DCQ showed good internal consistency, with most of the variance being explained by a single factor. Strong correlations with distress and work and social impairment lend face validity to the questionnaire. Dysmorphic concern was not significantly influenced by the patient's age, sex or diagnosis. In terms of specific psychotic symptoms, there were weak positive correlations with thought interference and persecutory ideation. However, the strongest correlations were with depressed mood, according to the Beck Depression Inventory (BDI) but not the Montgomery Asberg Depression Rating Scale; the discrepancy was largely accounted for by the 'cognitive' depressive items on the BDI. In terms of objective assessment of dysmorphic features, ratings on the Waldrop scale for minor physical anomalies showed no correlation with concern expressed by the patient.
CONCLUSIONS: The strong correlation with depressive cognitions suggests that dysmorphic concern is often a reflection of a depressive cognitive set rather than being a diagnosis in itself.

Entities:  

Mesh:

Year:  1998        PMID: 9565194     DOI: 10.3109/00048679809062719

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  43 in total

1.  Delusionality and response to open-label fluvoxamine in body dysmorphic disorder.

Authors:  K A Phillips; S L McElroy; M M Dwight; J L Eisen; S A Rasmussen
Journal:  J Clin Psychiatry       Date:  2001-02       Impact factor: 4.384

2.  The power within: The experimental manipulation of power interacts with trait BDD symptoms to predict interoceptive accuracy.

Authors:  Jonathan W Kunstman; Elise M Clerkin; Kateyln Palmer; M Taylar Peters; Dorian R Dodd; April R Smith
Journal:  J Behav Ther Exp Psychiatry       Date:  2015-08-10

Review 3.  Relationship between social anxiety disorder and body dysmorphic disorder.

Authors:  Angela Fang; Stefan G Hofmann
Journal:  Clin Psychol Rev       Date:  2010-08-14

4.  Emotional awareness, gender, and peculiar body-related beliefs.

Authors:  Matthew Tyler Boden; Sasha Gala; Howard Berenbaum
Journal:  Cogn Emot       Date:  2012-12-14

Review 5.  Physical manifestations of neurodevelopmental disruption: are minor physical anomalies part of the syndrome of schizophrenia?

Authors:  Michael T Compton; Elaine F Walker
Journal:  Schizophr Bull       Date:  2008-11-05       Impact factor: 9.306

6.  Body dysmorphic disorder, social anxiety and depressive symptoms in Chinese medical students.

Authors:  Yanhui Liao; Natalie P Knoesen; Yunlong Deng; Jinsong Tang; David J Castle; Riteesh Bookun; Wei Hao; Xiaogang Chen; Tieqiao Liu
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-09-27       Impact factor: 4.328

7.  Correlates of dysmorphic concern in people seeking cosmetic enhancement.

Authors:  David J Castle; Michael Molton; Keturah Hoffman; Neil J Preston; Katharine A Phillips
Journal:  Aust N Z J Psychiatry       Date:  2004-06       Impact factor: 5.744

8.  DISTINCT ETIOLOGICAL INFLUENCES ON OBSESSIVE-COMPULSIVE SYMPTOM DIMENSIONS: A MULTIVARIATE TWIN STUDY.

Authors:  Clara López-Solà; Leonardo F Fontenelle; Brad Verhulst; Michael C Neale; José M Menchón; Pino Alonso; Ben J Harrison
Journal:  Depress Anxiety       Date:  2015-12-02       Impact factor: 6.505

9.  The Body Image Concern Inventory: validation in a multiethnic sample and initial development of a Spanish language version.

Authors:  Heather Littleton; Carmen Radecki Breitkopf
Journal:  Body Image       Date:  2008-08-26

10.  Tanning addiction and psychopathology: Further evaluation of anxiety disorders and substance abuse.

Authors:  Lisham Ashrafioun; Erin E Bonar
Journal:  J Am Acad Dermatol       Date:  2013-12-25       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.